Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/18 → 31/08/22 |
Funding
- National Institute for Health and Care Research: £65,532.00
Sprionolactone for Adult Female Acne (SAFA): pragmatic multi-centre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of sprionolactone for moderate or severe persistent acne in women
- Sach, Tracey (Principal Investigator)
- Sach, Tracey (CTU Role)